Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global preventive healthcare technologies and services market 360° synopsis, 2018 – 2032
2.2 Regional trends
2.3 Type trends
2.4 End-use trends
Chapter 3 Preventive Healthcare Technologies and Services Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Growing burden of chronic diseases
3.5.1.2 Increasing adoption of digital healthcare technology
3.5.1.3 Growing number of awareness programs by the government.
3.5.1.4 Advancement in preventive healthcare technology
3.5.2 Industry pitfalls & challenges
3.5.2.1 Lack of healthcare IT professionals
3.5.2.2 Stringent regulatory scenario
3.6 Growth potential analysis
3.6.1 By type
3.6.2 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 GlaxoSmithKline
4.1.2 Abbott Laboratories
4.1.3 Merck & Co. Inc
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Preventive Healthcare Technologies and Services Market Size and Forecast, By Type, 2018-2032 (USD Million)
5.1 Key trends, by type
5.2 Early detection and screening
5.2.1 Automated screening
5.2.2 Personalized medicine
5.2.3 Other advanced screening technologies
5.3 Chronic disease management technologies
5.3.1 Blood pressure monitors
5.3.2 Asthma monitors
5.3.3 Cardiovascular monitors
5.3.4 Glucose monitors
5.4 Vaccines
5.4.1 Infectious diseases
5.4.2 Combined tetanus-diphtheria-pertussis vaccines
5.4.3 Allergy
5.4.4 Others
5.5 Advanced technologies to reduce errors
5.5.1 Electronic prescribing
5.5.2 Clinical decision support system
5.5.3 Smart infusion pumps
5.5.4 Computerized provider order entry system
5.5.5 Smart packaging
5.5.6 Automated prescription formulation & dispensing
Chapter 6 Preventive Healthcare Technologies and Services Market Size and Forecast, By End-use, 2018-2032 (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Clinics
6.4 Other end-users
Chapter 7 Preventive Healthcare Technologies and Services Market Size and Forecast, By Region, 2018-2032 (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East & Africa
Chapter 8 Company Profiles
8.1 GlaxoSmithKline
8.2 Omnicell, Inc
8.3 Myriad Genetics
8.4 Omron Healthcare
8.5 Abbott Laboratories
8.6 Medtronic
8.7 Quest Diagnostics
8.8 Merck & Co. Inc.
8.9 Sanofi
8.10 NOVX Systems Corp
8.11 Moderna, Inc
8.12 Pfizer
8.13 Teladoc Health
8.14 McKesson Corporation
8.15 Practice Fusion Inc
